MONMOUTH JUNCTION, N.J., May 31, 2012 /PRNewswire/ -- Tris Pharma, a technology driven specialty pharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved

ALLEGAN, Mich., May 30, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that the U.S.

MONMOUTH JUNCTION, N.J., May 10, 2012 /PRNewswire/ -- Tris Pharma, a technology driven specialty pharmaceutical company, announced today the joining of Ms.

MONMOUTH JUNCTION, N.J., Jan. 25, 2012 /PRNewswire/ -- Tris Pharma, an emerging specialty pharmaceutical company announced joining of a highly regarded Big Pharma executive Dr.

MONMOUTH JUNCTION, N.J., Aug. 18, 2011 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, has appointed Mr. Dominick DiPaolo to the position of Vice President of Quality, and Mr.